×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
HOLX – hologic, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
HOLX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/8
11:07 am
holx
US Digital Pathology Market worth US$2.01 billion by 2029 with 13.1% CAGR | MarketsandMarkets™ [Yahoo! Finance]
Medium
Report
US Digital Pathology Market worth US$2.01 billion by 2029 with 13.1% CAGR | MarketsandMarkets™ [Yahoo! Finance]
4/7
07:11 pm
holx
Hologic (HOLX) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]
Medium
Report
Hologic (HOLX) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]
4/7
10:07 am
holx
Hologic Brings in New Leadership: A Signal to Stay Put With the Stock? [Yahoo! Finance]
Low
Report
Hologic Brings in New Leadership: A Signal to Stay Put With the Stock? [Yahoo! Finance]
4/4
04:15 pm
holx
Wayde McMillan Elected to Hologic Board of Directors
Low
Report
Wayde McMillan Elected to Hologic Board of Directors
4/3
04:30 pm
holx
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025
Low
Report
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025
3/31
09:34 pm
holx
Hologic (HOLX) Outperforms Broader Market: What You Need to Know [Yahoo! Finance]
Low
Report
Hologic (HOLX) Outperforms Broader Market: What You Need to Know [Yahoo! Finance]
3/7
01:38 pm
holx
Why Is Hologic (HOLX) Down 4.5% Since Last Earnings Report? [Yahoo! Finance]
Low
Report
Why Is Hologic (HOLX) Down 4.5% Since Last Earnings Report? [Yahoo! Finance]
3/4
12:48 pm
holx
Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Citigroup Inc. from $80.00 to $70.00. They now have a "neutral" rating on the stock.
Low
Report
Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Citigroup Inc. from $80.00 to $70.00. They now have a "neutral" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/17
09:38 am
holx
Form SCHEDULE 13G/A HOLOGIC INC Filed by: BlackRock, Inc.
Low
Report
Form SCHEDULE 13G/A HOLOGIC INC Filed by: BlackRock, Inc.
4/9
04:17 pm
holx
Form 4 HOLOGIC INC For: Apr 07 Filed by: McMillan Wayde D.
Medium
Report
Form 4 HOLOGIC INC For: Apr 07 Filed by: McMillan Wayde D.
4/9
04:12 pm
holx
Form 3 HOLOGIC INC For: Apr 04 Filed by: McMillan Wayde D.
Medium
Report
Form 3 HOLOGIC INC For: Apr 04 Filed by: McMillan Wayde D.
4/4
04:16 pm
holx
Form 8-K HOLOGIC INC For: Apr 04
Low
Report
Form 8-K HOLOGIC INC For: Apr 04
3/3
08:15 am
holx
Form 8-K HOLOGIC INC For: Feb 26
Low
Report
Form 8-K HOLOGIC INC For: Feb 26
2/28
04:30 pm
holx
Form 4 HOLOGIC INC For: Feb 26 Filed by: Wendell Amy McBride
Low
Report
Form 4 HOLOGIC INC For: Feb 26 Filed by: Wendell Amy McBride
2/28
04:27 pm
holx
Form 4 HOLOGIC INC For: Feb 26 Filed by: Stewart Stacey D.
Low
Report
Form 4 HOLOGIC INC For: Feb 26 Filed by: Stewart Stacey D.
2/28
04:25 pm
holx
Form 4 HOLOGIC INC For: Feb 26 Filed by: Stamoulis Christiana
Low
Report
Form 4 HOLOGIC INC For: Feb 26 Filed by: Stamoulis Christiana
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/19
CDC, public labs have conducted 37,824 COVID-19 tests [MarketWatch]
6.5%
3/18 CDC, public health labs have conducted at least 31,000 tests [MarketWatch] 5.8%
4/23 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.1%
4/2 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Needham & Company LLC from $62.00 to $52.00. They now have a "buy" rating on the stock. 4.8%
4/8 Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair. 4.7%
11/20 Clayton, Dubilier & Rice to Acquire Market-Leading Medical Aesthetics Technology Company 4.3%
3/9 Form 4 HOLOGIC INC For: Mar 05 Filed by: HANTSON LUDWIG 4.0%
4/7 Form 8-K HOLOGIC INC For: Apr 07 2.9%
3/26 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Barclays PLC from $51.00 to $43.00. They now have an "equal weight" rating on the stock. 2.8%
1/31 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at TheStreet from a "c" rating to a "b+" rating. 2.7%
3/18 CDC, public health labs have conducted at least 31,000 tests [MarketWatch] 5.8%
4/23 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.1%
4/2 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Needham & Company LLC from $62.00 to $52.00. They now have a "buy" rating on the stock. 4.8%
4/8 Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair. 4.7%
11/20 Clayton, Dubilier & Rice to Acquire Market-Leading Medical Aesthetics Technology Company 4.3%
3/9 Form 4 HOLOGIC INC For: Mar 05 Filed by: HANTSON LUDWIG 4.0%
4/7 Form 8-K HOLOGIC INC For: Apr 07 2.9%
3/26 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Barclays PLC from $51.00 to $43.00. They now have an "equal weight" rating on the stock. 2.8%
1/31 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at TheStreet from a "c" rating to a "b+" rating. 2.7%
TOP News Decliners
3/17
Form 8-K HOLOGIC INC For: Mar 16
-11.4%
3/11 Form 4 HOLOGIC INC For: Mar 09 Filed by: CRAWFORD SALLY -9.9%
4/30 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Needham & Company LLC from $52.00 to $60.00. They now have a "buy" rating on the stock. -8.1%
3/20 CDC, public health labs performed at least 44,000 COVID-19 tests [MarketWatch] -5.9%
11/7 Hologic, Inc. (HOLX) CEO Steve MacMillan on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -5.3%
10/1 Hologic CEO Steve MacMillan to Ring Nasdaq Opening Bell on October 2 -4.5%
3/10 Form 8-K HOLOGIC INC For: Mar 05 -4.5%
8/14 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus to $62.00. They now have a "buy" rating on the stock. -4.4%
3/5 German Lab Demonstrates Feasibility to Detect SARS-Coronavirus-2 (SARS-CoV-2) Using Hologic’s Panther Fusion® System -4.3%
3/21 CDC, public health labs have tested at least 54,205 Americans for coronavirus [MarketWatch] -3.7%
3/11 Form 4 HOLOGIC INC For: Mar 09 Filed by: CRAWFORD SALLY -9.9%
4/30 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Needham & Company LLC from $52.00 to $60.00. They now have a "buy" rating on the stock. -8.1%
3/20 CDC, public health labs performed at least 44,000 COVID-19 tests [MarketWatch] -5.9%
11/7 Hologic, Inc. (HOLX) CEO Steve MacMillan on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -5.3%
10/1 Hologic CEO Steve MacMillan to Ring Nasdaq Opening Bell on October 2 -4.5%
3/10 Form 8-K HOLOGIC INC For: Mar 05 -4.5%
8/14 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus to $62.00. They now have a "buy" rating on the stock. -4.4%
3/5 German Lab Demonstrates Feasibility to Detect SARS-Coronavirus-2 (SARS-CoV-2) Using Hologic’s Panther Fusion® System -4.3%
3/21 CDC, public health labs have tested at least 54,205 Americans for coronavirus [MarketWatch] -3.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: